AUS
NZ
UK
CA
USA
FRA
GER
ESP
ITA
NLD
PRT
SWE
GRC
IND
POL
BRA
ZAF
RUS
CHN
UAE
Healthcare
ASX300: Mayne Pharma Addresses FDA Concerns Over Drug Communication
May 14, 2025 05:32 PM AEST| By Team Kalkine MediaHighlights,Mayne Pharma clarifies recent FDA correspondence,Shares drop over 15% following trading pause,FDA letter does not impact product distribution in the US,Mayne Pharma (ASX:MYX), a healthcare company listed on the Australian Securities Exchan...
Anteris Technologies (ASX:AVR) Q1 2025 Results: A Strategic Push in the ASX300 Space
May 14, 2025 04:32 PM AEST| By Team Kalkine MediaHighlights,Net sales decline while R&D investment surges,Strategic use of IPO funds supports pivotal clinical trial,Focus on scaling production for DurAVR® THV system,Anteris Technologies Global Corp. (ASX:AVR), a med-tech innovator now part of the b...
Lumos Diagnostics (ASX:LDX) Hits New Milestone with Largest FebriDx Order, Eyes Stronger ASX300 Performance
May 14, 2025 04:14 PM AEST| By Team Kalkine MediaHighlights,Lumos Diagnostics receives record FebriDx order,US$126,000 deal highlights growing US demand,FebriDx adoption rises after FDA clearance,Lumos Diagnostics (ASX:LDX), a key player in rapid diagnostic solutions, has announced a significant de...
Mayne Pharma Faces FDA Challenge Over Contraceptive Claims; Spotlight on ASX300 Healthcare Stock
May 14, 2025 04:07 PM AEST| By Team Kalkine MediaHighlights,Mayne Pharma withdraws presentation following FDA concerns,Company clarifies stance on product claims amid regulatory scrutiny,Shares react sharply, entering trading pause on ASX,Mayne Pharma Group (ASX:MYX), a pharmaceutical company liste...
Austco Healthcare Expands North American Reach with $2.1M Toronto Hospital Deal | Strong Play Among ASX300
May 14, 2025 03:53 PM AEST| By Team Kalkine MediaHighlights,Austco Healthcare (AHC) wins $2.1M tech contract in Canada,Strategic growth push in North America gains traction,Project supports long-term value amid rising ASX dividend stocks interest,Austco Healthcare (ASX:AHC) has further strengthened...
ASX300 Watch: Mayne Pharma Faces FDA Scrutiny Ahead of $663 Million US Deal
May 14, 2025 03:32 PM AEST| By Team Kalkine MediaHighlights,Mayne Pharma enters trading pause after FDA communication,12.2% share price drop triggers immediate halt,Regulatory concerns impact timing of upcoming acquisition,Shares of Australian pharmaceutical company Mayne Pharma (ASX:MYX) were plac...
ASX300 Spotlight: Mayne Pharma (ASX:MYX) Faces Trading Halt Amid FDA Review
May 14, 2025 03:10 PM AEST| By Team Kalkine MediaHighlights,Mayne Pharma (MYX) shares paused after sharp intraday drop,U.S. FDA questions product claims,regarding,contraceptive pill,Regulatory deadline looms for official company response,Mayne Pharma Group Limited (ASX:MYX), a pharmaceutical compan...
Anteris Technologies Scales Up for Pivotal PARADIGM Trial, Marking Big Steps in ASX200 Healthcare
May 14, 2025 11:38 AM AEST| By Team Kalkine MediaHighlights,Over 100 patients treated with,DurAVR,® in major clinical milestone,R&D investment ramps up for global PARADIGM Trial,Expanded manufacturing and regulatory progress highlight Q1 momentum,Australian medtech innovator Anteris Technologies (A...
AFT Pharmaceuticals (ASX:AFP) Expands Global Healthcare Reach Under ASX 200 Framework
May 14, 2025 11:30 AM AEST| By Team Kalkine MediaHighlights:,AFT Pharmaceuticals (ASX:AFP) operates in the pharmaceutical industry, known for its innovative non-opioid pain relief and diversified medical products.,The company maintains a broad international distribution network across key regions s...
Prescient Therapeutics (ASX:PTX) Cash Strategy Amid Rising Expenditures – ASX 200 Context
May 14, 2025 10:31 AM AEST| By Team Kalkine MediaHighlights:,Prescient Therapeutics (ASX:PTX) maintains a brief cash runway with increased cash usage year-over-year,The company recorded higher expenditure, coinciding with expansion activities and operational ramp-up,Share issuance remains a possibl...
Universal Biosensors (ASX:UBI) Financial Snapshot Amid Broader asx 200 Landscape
May 14, 2025 10:31 AM AEST| By Team Kalkine MediaHighlights:,Universal Biosensors (ASX:UBI) posts increased revenue alongside a deeper quarterly net loss,Share price experiences decline over recent sessions,Multiple red flags associated with financial performance,Universal Biosensors, operating (AS...
Orthocell Expands Remplir™ Reach into Hong Kong, Strengthening Global Presence Among ASX200 Growth Stories
May 13, 2025 11:59 AM AEST| By Team Kalkine MediaHighlights,Orthocell,gains fast-track regulatory approval in Hong Kong,Expands global footprint for,Remplir,™ nerve repair product,Eyes broader S&P/ASX200 exposure with strategic regional moves,Orthocell Ltd (ASX:OCC) has achieved another milestone i...
Tryptamine Therapeutics Appoints New Chairman to Drive Clinical Growth in Psychedelic Therapy
May 12, 2025 04:24 PM AEST| By Team Kalkine MediaHighlights:,Herwig Janssen appointed as new non-executive chairman of Tryptamine Therapeutics Ltd.,The company advances toward clinical trials using TRP-8803 to treat binge eating disorder.,Strengthened board with Chris Ntoumenopoulos transitioning t...
Bio-Gene Technology Launches Share Plan Amid Strategic Growth Focus in ASX200 Landscape
May 12, 2025 02:58 PM AEST| By Team Kalkine MediaHighlights,Bio-Gene (BGT) opens Share Purchase Plan post $2.1M raise,Eligible shareholders offered shares at $0.023 with bonus options,Proceeds to support Flavocide®, Qcide® and regulatory initiatives,Bio-Gene Technology Limited (ASX:BGT), an Austral...
Can ASX Tech Micro-Caps Sustain Momentum Amid Cash Burn Pressures on the ASX All Ordinaries?
May 11, 2025 04:30 PM AEST| By Team Kalkine MediaCan ASX Tech Micro-Caps Sustain Momentum Amid Cash Burn Pressures on the ASX All Ordinaries?
Is Lumos Diagnostics Limited Positioned for Growth Amid Valuation Concerns in the S&P/ASX 200 Index?
May 10, 2025 10:34 AM AEST| By Team Kalkine MediaIs Lumos Diagnostics Limited Positioned for Growth Amid Valuation Concerns in the S&P/ASX 200 Index?
Could Micro-X's Capital Activity Reflect Broader ASX Emerging Company Trends?
May 10, 2025 10:32 AM AEST| By Team Kalkine MediaCould Micro-X's Capital Activity Reflect Broader ASX Emerging Company Trends?
Is This Healthcare Stock on the ASX 50 and ASX 200 Reflecting Broader Sector Moves?
May 09, 2025 04:38 PM AEST| By Team Kalkine MediaIs This Healthcare Stock on the ASX 50 and ASX 200 Reflecting Broader Sector Moves?
Healius Ltd (ASX: HLS) Experiences Significant Decline as Shares Go Ex-Dividend
May 09, 2025 04:02 PM AEST| By Team Kalkine MediaHighlights:,Healius Ltd (ASX:HLS) shares drop sharply after going ex-dividend.,A special dividend following the sale of Lumus Imaging contributes to the decline.,Shareholders are set to receive a substantial fully franked dividend in the near future....
Orthocell (ASX:OCC) Expands US Rollout of Remplir, Outpaces Distribution Goals | ASX 200 Health Sector Update
May 09, 2025 02:05 PM AEST| By Team Kalkine MediaHighlights,Orthocell (ASX:OCC) secures distributor coverage across multiple US states for Remplir,Pre-launch groundwork includes medical education and hospital engagement strategies,Company preparing for further regulatory steps in Europe and the UK,...
Advertise your brand on Kalkine Media